{"id":33419,"date":"2014-10-09T09:45:12","date_gmt":"2014-10-09T13:45:12","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=33419"},"modified":"2014-10-09T09:45:12","modified_gmt":"2014-10-09T13:45:12","slug":"advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419","title":{"rendered":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 <strong>Advaxis, Inc. (NASDAQ:ADXS)<\/strong> disclosed that it has named Oncologist and research scientist, Samir Khleif, to its Board of Directors. He has over two decades of experience in the field of oncology, immunotherapy and tumor immunology.<\/p>\n<p style=\"text-align: justify;\"><strong>Ideal Addition<\/strong><\/p>\n<p style=\"text-align: justify;\">According to a statement issued to the media, the company said that Khleif\u2019s wide experience in both the business of oncology, as well as, science makes him a perfect addition to its board. The company expects to take advantage of his higher level of guidance and standards in its advancement of registrational trials, technology and much more.<\/p>\n<p style=\"text-align: justify;\">Currently, Khleif was the State of Georgia Cancer Center\u2019s Director, Cancer Service Line and Georgia Regents University Cancer Center. He was a former Chief of the National Cancer Institute\u2019s Cancer Vaccine Section. He was part of the Critical Path Initiative for oncology and was FDA Commissioner\u2019s Special Assistant.<\/p>\n<p style=\"text-align: justify;\">Khleif holds a professorship in Molecular Biology, Biochemistry and Medicine besides being a Cancer Scientist in Georgia Research Alliance.<\/p>\n<p style=\"text-align: justify;\"><strong>Research Program<\/strong><\/p>\n<p style=\"text-align: justify;\">Advaxis, Inc. (NASDAQ:ADXS) said that Khleif research in Georgia centered on cancer-induce immune suppression mechanisms understanding. He was using the knowledge gained to develop novel immune vaccines and therapeutics against cancer. The research group headed by him designed, as well as, performed some of the clinical trials for the first cancer vaccine aimed at particular genetic changes in cancer cells.<\/p>\n<p style=\"text-align: justify;\">Khleif was the author of several book chapters and articles on biomarkers process development and tumor immunology. He was also engaged in editing two textbooks on tumor immunology, cancer vaccines and cancer therapeutics.<\/p>\n<p style=\"text-align: justify;\"><strong>Management Comments<\/strong><\/p>\n<p style=\"text-align: justify;\">The company\u2019s President and CEO, Daniel O\u2019Connor, said that Khleif&#8217;s thorough knowledge of immunotherapy products would be very useful specifically for its technology of proprietary\u00a0Lm-LLO cancer immunotherapy.<\/p>\n<p style=\"text-align: justify;\">Advaxis, Inc. (NASDAQ:ADXS) said that it would look to benefit from Khleif\u2019s guidance as it works carefully to advance its\u00a0Lm-LLO cancer immunotherapies. It believes that the successful completion of the program would create shareholder value.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Advaxis, Inc. (NASDAQ:ADXS) disclosed that it has named Oncologist and research scientist, Samir Khleif, to its Board of Directors. He [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":33420,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[10515,8342,10550,8343,10549],"stock_ticker":[],"class_list":["post-33419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-advaxis-inc","tag-advaxis-inc-nasdaqadxs","tag-daniel-oconnor","tag-nasdaqadxs","tag-samir-khleif","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Advaxis, Inc. (NASDAQ:ADXS) disclosed that it has named Oncologist and research scientist, Samir Khleif, to its Board of Directors. He [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-09T13:45:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"298\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board\",\"datePublished\":\"2014-10-09T13:45:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\"},\"wordCount\":346,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg\",\"keywords\":[\"Advaxis Inc.\",\"Advaxis Inc. (NASDAQ:ADXS)\",\"Daniel O\u2019Connor\",\"NASDAQ:ADXS\",\"Samir Khleif\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\",\"name\":\"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg\",\"datePublished\":\"2014-10-09T13:45:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg\",\"width\":300,\"height\":298},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419","og_locale":"en_US","og_type":"article","og_title":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR","og_description":"Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Advaxis, Inc. (NASDAQ:ADXS) disclosed that it has named Oncologist and research scientist, Samir Khleif, to its Board of Directors. He [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-09T13:45:12+00:00","og_image":[{"width":300,"height":298,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board","datePublished":"2014-10-09T13:45:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419"},"wordCount":346,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg","keywords":["Advaxis Inc.","Advaxis Inc. (NASDAQ:ADXS)","Daniel O\u2019Connor","NASDAQ:ADXS","Samir Khleif"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419","url":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419","name":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg","datePublished":"2014-10-09T13:45:12+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/ADVAXIS.jpg","width":300,"height":298},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/advaxis-inc-nasdaqadxs-names-oncologist-samir-khleif-to-its-board-33419#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=33419"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/33420"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=33419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=33419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=33419"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=33419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}